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Regulation of the renal sympathetic
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Rohit Ramchandra* and Carolyn J. Barrett
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Heart failure (HF) is a serious debilitating condition with poor survival rates and an
increasing level of prevalence. HF is associated with an increase in renal norepinephrine
(NE) spillover, which is an independent predictor of mortality in HF patients. The excessive
sympatho-excitation that is a hallmark of HF has long-term effects that contribute to
disease progression. An increase in directly recorded renal sympathetic nerve activity
(RSNA) has also been recorded in animal models of HF. This review will focus on the
mechanisms controlling sympathetic nerve activity (SNA) to the kidney during normal
conditions and alterations in these mechanisms during HF. In particular the roles of
afferent reflexes and central mechanisms will be discussed.
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Introduction
Heart failure (HF) is a complex syndrome, arising secondary to a wide range of cardiac structural
and functional abnormalities, with the manifestations being shortness of breath, fatigue, exercise
intolerance, and oedema. Elevated sympathetic drive is well recognized to play a key role in
the pathophysiology of HF, with increased sympathetic nerve activity (SNA) to the kidneys
resulting in renal vasoconstriction, increased renal sodium retention and increased renin release,
and consequently elevated angiotensin II and aldosterone levels (DiBona and Kopp, 1997). In
turn, angiotensin II is known to drive adverse cardiac remodeling and deterioration in cardiac
function via a number of different pathways, including inflammatory pathways and fibrosis (Zhao
et al., 2014). While initially activation of renal sympathetic nerve activity (RSNA) may assist in
maintaining cardiac output, in the long-term neurohumoral activation drives the fluid overload
associated with HF, significantly impacting both morbidity and mortality.
The significance of the sympathetic activation in HF is highlighted by the successful use of
ACE inhibitors and β-blockers in the clinical management of the syndrome (Yancy et al., 2013).
β-Blockers are well established to reduce the rate of mortality (Esler and Kaye, 1998), however,
even when the majority of patients are prescribed β-blockers, increased renal norepinephrine (NE)
spillover is directly linked to mortality (Petersson et al., 2005). Kidney function is an important
determinant of outcomes during HF, with glomerular filtration rate, being an independent
predictor of mortality in HF (Hillege et al., 2006). Understanding the mechanisms regulating renal
function, and the changes that occur during the development of HF is thus crucial in understanding
the pathophysiology of HF. In this review we will review the evidence for an increase in RSNA
in HF and focus on three key areas potentially involved in mediating the changes: the arterial
baroreceptors, the peripheral chemoreceptors, and the central regulation of RSNA within the
paraventricular nucleus of the hypothalamus. A more in depth discussion of additional afferent
signals such as from cardiopulmonary volume receptors and the afferent kidney reflex in control of
RSNA in HF is presented by Booth et al. in this same special edition.
Ramchandra and Barrett RSNA and HF
Resting Levels of Renal Sympathetic Nerve
Activity in HF
Early studies in patients with severe HF have indicated that
the spillover of NE from the kidney is increased (Hasking
et al., 1986; Aggarwal et al., 2003). Figure 1 illustrates the
progressive increase in spillover of NE from the kidney observed
in clinical studies. As the figure indicates, as the progression of
HF reaches ejection fractions of below 30%, there is a significant
increase in renal spillover of NE. Rundqvist et al. (1997) indicate
that at ejection fractions of 29 ± 7%, the renal spillover of
NE is not significantly different to a normal matched cohort.
However, once ejection fraction decreases below 25%, there is
a significant increase in renal spillover of NE. Interestingly at
ejection fractions of 29%, a three-fold increase in cardiac spillover
of NE is observed indicating that the increase in cardiac spillover
of NE occurs earlier than that in the kidney (Rundqvist et al.,
1997).
An increase in spillover of NE from the kidney may be driven
by changes in directly recorded SNA or may be secondary to
changes in reuptake of NE at the synapse. Various animal models
have been employed to study the role of the renal sympathetic
nerves in HF. These include the myocardial infarction (MI)
induced HF model in the rat and pacing induced HF in the
rabbit, sheep, and the dog. The majority of studies have indicated
an increase in directly recorded RSNA during HF with ejection
fractions of 36–45%. The MI induced model of HF in rodents
results in a significant increase in baseline resting levels of RSNA
(DiBona et al., 1996, 1997). Similar to this, the pacing induced
model of HF in rabbits is also associated with an increase in
baseline levels of sympathetic drive to the kidney (Sun et al.,
1999a; Liu et al., 2000). The finding of a significant increase
in RSNA is not universal in all animal models of HF. Previous
FIGURE 1 | Renal norepinephrine (NE) spillover increases as the
ejection fraction decreases in separate groups of heart failure patients
(individual numbers taken from Rundqvist et al., 1997; Brunner-La
Rocca et al., 2001; Al-Hesayen and Parker, 2004, 2008; Petersson et al.,
2005). Note the straight line indicates the average baseline renal NE spillover in
normal age-matched controls (taken from Rundqvist et al., 1997; Petersson
et al., 2005).
studies have found that baseline levels of RSNA are not increased
in doxorubicin induced HF (Rossi et al., 2008) or in pacing
induced HF in sheep (Ramchandra et al., 2009a). Given the
progressive increase in renal spillover of NE as HF worsens, it
is possible that these findings merely reflect models of HF which
are not severe enough.
Clinical Relevance
It is interesting that animal models of HF that have indicated
an increase in RSNA show increases at ejection fractions of 50%
while clinically at the same stage of HF, there is no increase
in renal spillover of NE. Considering this discrepancy, it is
important to note that the majority of HF patients are on
medications in particular ACE inhibitors and angiotensin II
receptor blockers. Given that angiotensin II has been shown
to facilitate release of NE from sympathetic nerve endings
(Johnson et al., 1974; Burgdorf et al., 2003), it is tempting
to speculate that any effects of RSNA in moderate stages of
HF may be attenuated by these drugs although direct evidence
of this is currently lacking. In addition, the re-uptake of NE
at the synapse in the kidney is lower compared to the heart
and this has meant that the role of reuptake mechanisms in
modulating spillover of NE in the kidney has not been adequately
explored.
The Role of Afferent Inputs in Regulating
RSNA
The regulation of RSNA is dependent on the integration of
many afferent inputs, including the cardiopulmonary receptors,
cardiac chemoreceptor afferents, and feedback from muscle
receptors (Figure 2). In HF the general consensus is that there
is a blunting of the inhibitory reflexes, including the arterial
and cardiopulmonary baroreceptors and an increase in the
sensitivity of the excitatory reflexes, including the peripheral
chemoreceptors, cardiac chemosensory afferent reflexes, and
muscle metaboreceptors (as reviewed by Floras, 2009; Zucker
et al., 2012). Recently focus has been drawn to the role of the
arterial baroreceptor reflex and the peripheral chemoreceptors,
due to the potential to modulate these reflexes clinically. We will
focus on these two afferent reflexes.
Arterial Baroreceptor Reflex
Perhaps the most well recognized modulator of SNA is the
arterial baroreceptor reflex. With receptors located primarily
in the carotid sinus and aortic arch any increase in stretch
of the arterial wall results in an increase in firing of
afferent baroreceptor nerve activity. Stimulation of the arterial
baroreceptors results in inhibition of SNA, playing an important
role in buffering rapid changes in arterial pressure (Lohmeier
and Iliescu, 2015). While initial studies suggested that the arterial
baroreflex plays a minor role in chronic regulation, more recent
studies indicate arterial baroreceptor reflexes are capable of
regulating arterial pressure over much longer periods (Thrasher,
2005; Lohmeier et al., 2009). Sustained baroreflex-mediated
inhibition of RSNA is observed in response to increases in arterial
pressure induced by pressor doses of angiotensin II in both rats
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FIGURE 2 | Schematic showing the afferent reflexes which modulate renal sympathetic nerve activity during heart failure. NTS, Nucleus of the solitary
tract; RVLM, rostral ventral lateral medulla; CVLM, caudal ventral lateral medulla; PVN, paraventricular nucleus of the hypothalamus.
and rabbit models (Barrett et al., 2003, 2005; Yoshimoto et al.,
2010), suggesting that the baroreflex is capable of influencing
RSNA chronically. Whether the baroreflex plays a role in driving
the changes in RSNA observed during HF remains controversial.
Most reports have suggested that in HF arterial baroreflex control
of RSNA is blunted, with a reduced sensitivity (DiBona et al.,
1995; Murakami et al., 1997) and often also a reduced range of
control (DiBona and Sawin, 1994; Liu et al., 1996; Zhang et al.,
1999). As a consequence it is often argued that blunting of the
arterial baroreflex may play a permissive role in HF, allowing
the excitatory reflexes to predominate, resulting in an increase
in RSNA (DiBona and Sawin, 1995). However, there is growing
evidence that the arterial baroreflex regulation of RSNA in HF is
more complicated than first presented. Recent research suggests
that the degree of HF, female sex, and methods of normalizing
RSNA can all influence the interpretation of data (Pinkham et al.,
2015). Pinkham et al. showed that a blunting of arterial baroreflex
regulation of RSNA was positively associated with deterioration
in left ventricular function in males and ovariectomized females,
but not ovary intact females, and only when the data was
normalized (Pinkham et al., 2015). These findings fit with those
of Ramchandra et al. (2009a) who have demonstrated that
arterial baroreflex control of RSNA is unaltered in conscious
female sheep with mild pacing induced HF. It should also be
noted that elevations in plasma NE levels are still observed with
the development of HF in dogs with baroreceptor denervation
(Brändle et al., 1996). Thus, while the majority of studies suggest
that at least in males with severe HF there may be an impaired
ability of the baroreflex to inhibit RSNA, it is difficult to suggest
that the arterial baroreceptor reflex is the primary driver for
the increase in RSNA associated with HF. Furthermore, clinical
studies suggest that whilst baroreflex control of heart rate (HR) is
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impaired in HF, there is little evidence to suggest that impairment
of the baroreceptor reflex control of muscle SNA plays a role in
driving the increase in muscle SNA (Floras, 2009).
Peripheral Chemoreflex
The carotid body (CB) is the most perfused organ per gram
weight in the body [2000ml min−1 (100mg tissue)−1]. It receives
its blood supply via an arterial branch arising from the internal
or external carotid artery, which ensures that the CB responds
acutely to changes in arterial oxygen levels and other contents
(e.g., CO2, acidotic pH, hypoglycaemia, and hypoperfusion).
Stimulation of the CB drives an increase in systemic sympathetic
tone through direct signaling to the nucleus tractus solitarii
and rostral ventrolateral medulla (Marshall, 1994). The CB
chemoreflex not only serves as a protective mechanism during
hypoxia (Prabhakar, 2013), but also contributes eupnoeic drive to
breathing and control of blood flow during exercise (Dempsey,
2012). Activation of the CB by hypoxia or chemical stimuli
increases respiratory drive and SNA to various vascular beds
(Xing and Pilowsky, 2010), including the heart (Kollai et al.,
1978).
More recently the role of the CB chemoreflex has been
implicated in mediating the increased RSNA during HF (Li
et al., 2005, 2006; Schultz and Li, 2007; Ding et al., 2011)
and hypertension (McBryde et al., 2013; Paton et al., 2013;
Moraes et al., 2015). In a rabbit model of pacing-induced HF,
Schultz and colleagues have documented that maladaptive CB
activity not only contributes to the enhanced RSNA response to
hypoxia (Ding et al., 2011), but also provides a tonic excitatory
influence to increase RSNA (Sun et al., 1999b). This enhanced
responsiveness appears to be mediated at least in part by the CB
chemoreflex, and depends on reduced CB blood flow, increased
angiotensin II, and down-regulation of nitric oxide (NO) (Li
et al., 2005, 2006; Ding et al., 2011). Importantly, inhalation
of 100% oxygen decreased RSNA levels in pacing-induced HF
animals to a greater extent than in normal animals (Sun et al.,
1999b), suggesting a tonic excitatory input from this reflex.
Interestingly, acute inhibition of the CB also reduces cardiac
SNA (Xing et al., 2014) and consistent with this, denervation of
the CB has led to an improvement in heart function (Del Rio
et al., 2013) further strengthening the case for targeting the CB
in HF.
Clinical Relevance
In clinical studies, the issue is less clear with some reports finding
that breathing 100% oxygen does not decrease muscle SNA in
HF (van de Borne et al., 1996), whereas others have found
reduced SNA suggesting a role for tonic chemoreflex activation
(Despas et al., 2009; Franchitto et al., 2010). This discrepancy is
probably due to the variety of methods used to assess peripheral
chemoreflex sensitivity, and the patients selected for the studies.
The discrepancy could also reflect differential control of SNA to
the muscle and the kidney. Additionally and more importantly,
only 40% of patients with HF indicate an augmented response
to the chemoreflex (Chua et al., 1997). This was classified as
an increase in ventilation rate during hypoxia induced using
transient inhalations of 100% nitrogen. We can conclude that
there is clearly a large percentage of the HF population where
any putative increases in RSNA are driven by other mechanisms.
Why some patients are sensitive to the chemoreflex but others
not remains unclear. This may be related to anemia induced
by HF since one previous study has shown that deactivation of
chemoreceptors reduces muscle SNA in chronic HF patients with
anemia but does not change levels of muscle SNA in chronic HF
patients with no anemia (Franchitto et al., 2010). These subtleties
of HF have not been adequately reproduced in animal models of
HF and remain an important area where more basic research is
required.
Central Regulators of RSNA
We will now shift focus from the afferent reflexes to central
brain regions which integrate the input of these reflexes. In
this context, sympathetic drive to various organs arises from
sympathetic premotor neurons in the central nervous system.
These include the “traditional” sympathetic premotor regions
such as the rostral ventral lateral medulla, the rostral ventral
medial medulla, the medullary raphe, the paraventricular nucleus
of the hypothalamus (PVN), and the A5 noradrenergic cell group
(Strack et al., 1989; Schramm et al., 1993) as well as recent
additions including the locus coeruleus, lateral hypothalamus,
and periaqueductal gray (Cano et al., 2004), Barrington’s nucleus
(Cano et al., 2000) and subcoeruleus nucleus (Cano et al., 2004).
When it comes to ascertaining the central brain regions involved
in regulating sympathetic drive to the kidney the majority of
studies have focused on the PVN due to the important role
this region plays in blood volume regulation. Anatomically
the PVN includes vasopressin-producing magnocellular neurons
and parvocellular neurons which project to both the spinal
preganglionic sympathetic neurons and premotor sympathetic
neurons in the brain stem (Shafton et al., 1998). Moreover,
plasma and CSF [Na+] aremonitored via sodium/osmo receptors
in the lamina terminalis (McKinley et al., 2003) and studies have
indicated an important pathway from the lamina terminalis to
the PVN in mediating changes in RSNA (May et al., 2000; Shi
et al., 2007).
Role of the PVN in Mediating Increased RSNA
during HF
Previous studies that have examined the role of the PVN in
the baseline control of RSNA in normal animals have found
variable effects. Microinjection of muscimol, a GABA receptor
agonist into the PVN, results in increases (Badoer et al., 2002),
decreases (Zhang et al., 2002; Akine et al., 2003), or no change
in resting levels of RSNA (Ng et al., 2004; Stocker et al., 2004,
2005; Ramchandra et al., 2013). These different RSNA responses
are likely to be due to the effects of anesthesia in previous
studies, as anesthesia can significantly modify the responses to
stimulation of the PVN (Kannan et al., 1989). These data suggest
that in conscious animals, there is little contribution by the PVN
to baseline levels of RSNA, although we cannot categorically
rule out a tonic inhibitory role of the PVN in mediating
baseline levels of RSNA (Zhang et al., 2002; Ramchandra et al.,
2013).
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In contrast to normal animals, the PVN appears to play an
important role in mediating the high resting levels of RSNA
observed in animal models of HF. Activation of the PVN in
HF is indicated by the increased expression of c-fos as well as
Fos related antigens in neurons in the PVN (Vahid-Ansari and
Leenen, 1998; Patel et al., 2000). More importantly, studies in a
rat model of HF indicate that activation of the PVN contributes
to the increased levels of RSNA (Li and Patel, 2003; Zheng
et al., 2009). Microinjection of muscimol into the PVN of rats
with HF results in diminished depressor responses in MAP, HR,
and RSNA (Patel, 2000; Zhang et al., 2002; Wang et al., 2009)
suggesting a reduction in the GABAergic inhibitory input to the
PVNmaymediate the increase in baseline levels of RSNA (Carillo
et al., 2012).
In terms of neuromodulators involved, studies have focused
on the role of NO within the PVN. Reduced synthesis of NO,
due to down regulation of the neuronal isoform of nitric oxide
synthase (NOS), has been suggested as a cause of the centrally
mediated sympathoexcitation in HF. In conscious normal rats,
unilateral PVN microinjections of the NO donor, sodium
nitroprusside (SNP) (0.5–1.0 M, about 13–26µg), decreased
MAP (Martins-Pinge et al., 2012). This is also associated with
a decrease in RSNA in anesthetized rats (Zhang et al., 1997)
indicating a sympathoinhibitory action of NO within the PVN.
Although the inhibition of RSNA in these studies is likely a
direct central effect of SNP, as the renal inhibition occurred in
the presence of a fall in blood pressure, it is important to note
that the intravenous dose of SNP required to produce large falls
in blood pressure in rats is 5–10µg. This raises the possibility
that changes observed after SNP infusions or microinjections
may result from supraphysiological increases in NO levels. In this
regard, studies with inhibition of NOS are clearer to interpret.
Acute inhibition of central NOS with the nonselective inhibitor
Nω-nitro-l-arginine methyl ester (l-NAME), microinjected in the
PVN increased baseline levels of RSNA (Zhang et al., 1997; Zhang
and Patel, 1998). These findings suggest that NO within the
PVN regulates baseline levels of RSNA in rodents however it is
important to note that in conscious sheep and rabbits, this is not
the case (Ng et al., 2004; Ramchandra et al., 2014).
Previous studies have indicated that neuronal NOS (nNOS)
levels are decreased in HF, in particular, in neurons of the
PVN (Patel et al., 1996a; Zhang et al., 1998; Ramchandra
et al., 2014). The functional importance of this as a cause of
the increased RSNA in HF is shown by the beneficial effects
of nNOS gene transfer into the PVN (Zheng et al., 2011).
Administration of a recombinant adenovirus that overexpressed
nNOS resulted in an attenuated increase in HR and RSNA due to
microinjection of N-methylD-aspartic acid into the PVN (Zheng
et al., 2011). These studies indicate that during HF the PVN
is at least partly responsible for the increase in baseline levels
of RSNA.
Studies have also examined the role of the PVN in modulating
the reflex regulation of RSNA. The primary reflex studied in this
regard has been the cardiopulmonary afferent reflex. In essence,
an increase in circulating blood volume using infusion of plasma
or plasma expanders results in an increase in renal blood flow
that is mediated by a decrease in SNA to the kidney. In this
context, the PVN plays a critical role in mediating this inhibition
of RSNA in a variety of species (Badoer et al., 2002; Li et al.,
2003; Ramchandra et al., 2013). For example, microinjection of
muscimol into the PVN caused attenuation of the inhibition
of RSNA during volume expansion in conscious rabbits (Ng
et al., 2004) and sheep (Ramchandra et al., 2013). Furthermore,
lesions of the PVN in anesthetized rats attenuated the inhibition
of RSNA and renal vasodilatation following volume expansion
(Lovick et al., 1993; Haselton et al., 1994). Together these data
indicate that in the normal state volume expansion stimulates
a reflex that increases the level of GABAergic inhibitory input
into the PVN and inhibits RSNA. In contrast, volume expansion
during HF fails to activate central pathways (Akama et al., 1998)
and results in an attenuated decrease in RSNA (Dibner-Dunlap
and Thames, 1992; Patel et al., 1996b; Ramchandra et al., 2009b).
Interestingly, this attenuated inhibition of RSNA during volume
expansion is restored post exercise training (Pliquett et al., 2003;
Zheng et al., 2006) probably mediated by an up-regulation of
nNOS positive neurons within the PVN (Zheng et al., 2005).
It must be mentioned that in anesthetized animals,
disinhibition of the PVN attenuates the RSNA inhibition in
contrast to conscious animals where inhibition of the PVN
attenuated the RSNA inhibition. One important unanswered
question is how inhibition of the PVN leads to an inhibition
of RSNA. In this context, there are numerous inhibitory
interneurons in the PVN. When muscimol is microinjected into
the PVN, it is still unclear what subsets of neurons are being
inhibited and whether inhibition of inhibitory interneurons
occurs. This makes it hard to decipher neuronal networks within
the PVN. Irrespective of these limitations, the PVN plays an
important role in reflex regulation of RSNA and appears to be
important in mediating the impaired reflex regulation of RSNA
during HF.
Conclusions
Understanding the role of RSNA in HF is difficult in humans
where measurement is indirect at best. When considering
findings from animal studies we must be mindful that the degree
and model of HF, species and sex of the animals and presence
of anesthesia all add complexity to the interpretation. Evidence
does suggest that deterioration in cardiac function inHF is closely
associated with elevations in RSNA, although it would appear
that increased NE spillover only becomes significant once the
ejection fraction is reduced below 30%. The exact mechanisms
driving the increase in RSNA remain controversial, in part
reflecting the diverse nature of the origins of HF. While any
changes in sensitivity of the reflex regulation of SNA may simply
be secondary to the increase in RSNA, there is emerging evidence
that, at least in some instances, the peripheral chemoreceptors
may be involved in driving the increase in RSNA. While in
severe HF, there may be an impaired ability of the baroreflex to
inhibit RSNA in males, it is difficult to suggest that the arterial
baroreceptor reflex is the primary driver for the increase in
RSNA. Additionally HF is characterized by impaired regulation
of body water content. The PVN is highlighted as one central
area which is associated with the impairment of the regulation
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of blood volume in HF, with an impaired ability of the PVN to
inhibit RSNA in response to the increased blood volume observed
in HF. Understanding the drivers for the increased RSNA and the
variability that occurs between individuals is key to the successful
management of HF.
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